<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
Date of Report (Date of earliest event reported):
July 27, 1999
AMERICAN HOMEPATIENT, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19532 62-1474680
- --------------- ----------- ---------------
(State or other (Commission I.R.S. Employer
jurisdiction of File Number) Identification
incorporation) Number)
5200 Maryland Way, Suite 400, Brentwood, Tennessee 37027-5018
-------------------------------------------------------------
(Address of principal executive offices)
(615) 221-8884
----------------------------------------------------
(Registrant's telephone number, including area code)
Not Applicable
----------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
-------------------------------------------------------------------------
Exhibit Index on Page 2
Page 1 of 3
<PAGE> 2
ITEM 5. OTHER EVENTS.
The Registrant reports that on July 27, 1999 it received notification
that the Nasdaq National Market will de-list the Registrant's common stock
effective at the close of business on August 31, 1999. Currently, the Registrant
is pursuing the listing of its common stock on the American Stock Exchange
(AMEX). Unless AMEX has approved the Registrant for trading, beginning September
1, 1999 trading of the Registrant's common stock will be conducted on the
over-the-counter market, also known as the "OTC" or, on application by
broker-dealers, in the NASD's Electronic Bulletin Board using the company's
current trading symbol, AHOM.
The Registrant has issued a press release regarding these events, a
copy of which is attached as Exhibit 99.1 and incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned thereunto duly authorized.
AMERICAN HOMEPATIENT, INC.
By: /s/ Marilyn O'Hara
-----------------------------------------
Name: Marilyn O'Hara
---------------------------------------
Title: Chief Financial and Accounting Officer
---------------------------------------
Date: July 27, 1999
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit No. Description Page
- ----------- ----------- ----
<S> <C> <C>
99.1 Press Release 3
</TABLE>
Page 2 of 3
<PAGE> 1
EXHIBIT 99.1
AMERICAN HOMEPATIENT PRESS RELEASE
Contacts: Joseph F. Furlong or Kathey S. Palmer
President and CEO Sr. Vice President
(615) 221-8884 (615) 221-8884
FOR IMMEDIATE RELEASE
AMERICAN HOMEPATIENT DE-LISTED FROM NASDAQ NATIONAL MARKET
--------------------------------------------------------------------
BRENTWOOD, Tn. (July 28, 1999) - American HomePatient, Inc. (NASDAQ: AHOM)
received notification that the Nasdaq National Market will de-list the company's
common stock effective at the close of business on August 31, 1999 because the
company failed to meet the minimum bid price requirement of $5.00. The company
previously announced that Nasdaq was considering this matter and the company was
exploring other listing options. Currently, American HomePatient is pursuing the
listing of its common stock on the American Stock Exchange (AMEX).
Unless AMEX has approved the company for trading, beginning September 1, 1999
trading of American HomePatient's common stock will be conducted on the
over-the-counter market, also known as the "OTC" or, on application by
broker-dealers, in the NASD's Electronic Bulletin Board using the company's
current trading symbol, AHOM.
American HomePatient is one of the largest home health care companies in the
country with over 300 centers in 38 states. Its primary product and service
offerings include home respiratory services, infusion therapy, parenteral and
enteral nutrition, and home medical equipment. The company's common stock
currently trades on the Nasdaq stock market under the symbol AHOM.
Certain statements made in the press release may constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995. Such forward-looking statements are based on management's current
expectations and include known and unknown risks, uncertainties and other
factors, many of which the company is unable to predict or control, that may
cause the company's actual results or performance to materially differ from any
future results or performance expressed or implied by such forward-looking
statements. These statements involve risks, uncertainties and other factors
detailed from time to time in the company's filings with the Securities and
Exchange Commission. Such factors may include the increased cost of borrowing
under the company's credit agreement, changes to the company's business strategy
and operation, the effect of healthcare legislation and regulation, the ability
to obtain business, and the outcome of ongoing governmental investigations. The
company cautions investors that any forward-looking statements made by the
company are not necessarily indicative of future performance.
Page 3 of 3
